# Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer

> clinical trial · VERIFIED · 2026-07-21

Status: ACTIVE_NOT_RECRUITING · Sponsor: Alexander B Olawaiye, MD · Condition: Ovarian Cancer

- Company: Alexander B Olawaiye, MD
- Sector: Ovarian Cancer
- Primary source: https://clinicaltrials.gov/study/NCT05467670

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.